Fast Five Quiz: Tardive Dyskinesia Causes and Associated Conditions

Authors and Disclosures

Author(s)

Christoph U. Correll, MD

Professor of Psychiatry and Molecular Medicine, Department of Psychiatry; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York; Medical Director, Recognition and Prevention Program, Zucker Hillside Hospital, Glen Oaks, New York

Disclosure: Christoph U. Correll, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, partner, employee, advisor, consultant, or trustee for: Alkermes; Allergan; Angelini; Boehringer Ingelheim; Gedeon Richter; Gerson Lehrman Group; Indivior; Intra-Cellular Therapies; Janssen/Johnson & Johnson; LB Pharmaceuticals; Lundbeck; MedAvante-ProPhase; Medscape; Merck; Neurocrine Biosciences; Noven Pharmaceuticals; Otsuka; Pfizer; Recordati; ROVI; Servier; Sumitomo Dainippon Pharma; Sunovion; Supernus Pharmaceuticals; Takeda; Teva
Provided expert testimony for: Bristol-Myers Squibb; Janssen; Otsuka
Serve(d) as a speaker for: Allergan; Angelini; Gedeon Richter; Janssen/Johnson & Johnson; Lundbeck; Merck; Otsuka; Pfizer; Recordati; Servier; Sunovion
Received research grant from: Janssen; Takeda
Received income in an amount equal to or greater than $250 from: Alkermes; Allergan; Angelini; Boehringer-Ingelheim; Gedeon Richter; Gerson Lehrman Group; Indivior; Intra-Cellular Therapies; Janssen/Johnson & Johnson; LB Pharmaceuticals; Lundbeck; MedAvante-ProPhase; Medscape; Merck; Neurocrine Biosciences; Noven Pharmaceuticals; Otsuka; Pfizer; Recordati; ROVI; Servier; Sumitomo Dainippon Pharma; Sunovion; Supernus Pharmaceuticals; Takeda; Teva
Serve(d) on the Data Safety Monitoring Board for: Boehringer-Ingelheim; Lundbeck; ROVI; Supernus Pharmaceuticals; Teva
Receives royalties for: UpToDate
Shareholder for: LB Pharmaceuticals